PharmaEssentia USA Corporation Selects Veeva Data Cloud To Support Launch Of Novel Therapy For Rare, Chronic Blood Cancer

Insights into the full patient journey will speed the path to diagnosis for niche patient populations

Veeva Systems announced that PharmaEssentia has adopted Veeva Data Cloud to support the launch of BESREMi, a new therapy approved for adults with polycythemia vera (PV), a rare blood cancer. Veeva Longitudinal Patient Data will provide essential insights to help the company reach hard-to-find patient populations through healthcare provider (HCP) targeting and patient journey analytics.

Recommended AI News: Keysight First to Gain GCF Approval for Test Case Verifying IMS Based eCall Functionality

“Veeva Data Cloud has been a great asset for our commercial go-to-market operations and launch strategy,” said Roddy McIlwain, SVP, Sales and Marketing at PharmaEssentia U.S.A Corporation. “In our specialized market, the dynamics are complex. With Veeva Data Cloud, we have access to anonymized patient-level historical diagnoses, concomitant treatments, and medical procedures, across all therapeutic areas. This enhanced visibility gives us a deeper understanding of the full patient experience and helps us find and engage the right prescribing HCPs.”

“PharmaEssentia is an innovative biotechnology company taking a data-driven approach to its product launch,” said Asaf Evenhaim, CEO, Veeva Crossix. “With Veeva Data Cloud, PharmaEssentia gains a single data source to support multiple commercial analytics and operations workflows so the company can better educate healthcare professionals on its new treatment option.”

Recommended AI News: HJF Administering Study Seeking To Expand Specialized Care Across The Military Health System

The company’s adoption of Veeva Data Cloud builds on its long-term success with other applications from the Veeva Commercial Cloud, including solutions for multichannel engagement and commercial content. These capabilities facilitate smarter, compliant HCP interactions across all channels.

Veeva Data Cloud brings together diverse data assets, including retail and specialty pharmacy distribution channels, as well as insurers and pharmacy benefit managers (PBMs) in the U.S. market. Veeva Data Cloud is powered by the Veeva Crossix Data Platform, a world-class technology platform built for the development and delivery of large-scale patient data and analytics.

Recommended AI News: Hospital IQ Expands Reach of Operational Excellence Technology with Siemens Healthineers

[To share your insights with us, please write to sghosh@martechseries.com]